Clinical Trial: THCV Lowers Blood Sugar Levels In Type 2 Diabetics | Paul Armentano
DERBY, UK — The administration of THCV (tetrahydrocannabivarin), a non-psychoactive component of cannabis, is positively associated with glycemic control in type 2 diabetics, according to the randomized, placebo-controlled data published in the journal Diabetes Care. Investigators from the University of Nottingham, School of Medicine assessed the twice daily administration of various cannabinoids (CBD or THCV or […]
Clinical Trial: THCV Lowers Blood Sugar Levels In Type 2 Diabetics | The Daily Chronic